There’s no doubt that cannabis legalization is sweeping the globe, but the rate at which regions are opening and the priorities of countries varies greatly. Europe’s market and infrastructure lags behind the U.S. and the focus continues to be on the medical market. But with U.S. MSOs like Curaleaf acquiring cannabis companies in Europe, momentum is building. In this episode, Stephen Murphy, Co-founder and Managing Director of Prohibition Partners discusses what the current cannabis landscape looks across Europe and what opportunities are ripe for investors and companies.